Education
About Us
Working with TipRanks
Follow Us
Orion (0M2O) (GB:0M2O)
:0M2O
0M2O Stock Chart & Stats
Day’s Range― - ―
52-Week Range€31.87 - €57.70
Previous CloseN/A
Volume5.12K
Average Volume (3M)42.82K
Market Cap
€6.82B
Enterprise Value€6.98B
Total Cash (Recent Filing)€205.60M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)20.7
Beta0.76
Next Earnings
Apr 23, 2025EPS Estimate
0.41Last Dividend Ex-Date
Apr 04, 2025Dividend Yield3.34%
Share Statistics
EPS (TTM)2.35
Shares Outstanding108,382,010
10 Day Avg. Volume31,212
30 Day Avg. Volume42,819
Financial Highlights & Ratios
PEG Ratio0.40
Price to Book (P/B)N/A
Price to Sales (P/S)4.41
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Bulls Say, Bears Say
Bulls Say
EarningsNubeqa is expected to drive consensus EPS upgrades, improving Orion's ability to raise the dividend, which is crucial for local investors.
Product PortfolioOpevesostat (ODM-208) could sustain growth into the 2030s, with potential peak sales of €1.1 billion and Orion eligible to receive $1.6 billion in milestones.
Sales OutlookNubeqa's peak sales are projected to reach €1.3 billion, backed by Bayer's optimistic outlook, positive doctor feedback, and strong IQVIA script trends.
Bears Say
CompetitionNubeqa faces competition from Xtandi and Erleada, although it is preferred by doctors for better tolerability and flexibility in use with comorbidities.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
5.35%
Mutual Funds
― Other Institutional Investors
82.37% Public Companies and
Individual Investors
0M2O FAQ
What was Orion (0M2O)’s price range in the past 12 months?
Orion (0M2O) lowest share price was €31.87 and its highest was €57.70 in the past 12 months.
What is Orion (0M2O)’s market cap?
Orion (0M2O)’s market cap is €6.82B.
When is Orion (0M2O)’s upcoming earnings report date?
Orion (0M2O)’s upcoming earnings report date is Apr 23, 2025 which is in 11 days.
How were Orion (0M2O)’s earnings last quarter?
Orion (0M2O) released its earnings results on Feb 25, 2025. The company reported €0.52 earnings per share for the quarter, beating the consensus estimate of €0.492 by €0.028.
Is Orion (0M2O) overvalued?
According to Wall Street analysts Orion (0M2O)’s price is currently Overvalued.
Does Orion (0M2O) pay dividends?
Orion (0M2O) pays a Annually dividend of €1.629 which represents an annual dividend yield of 3.34%. See more information on Orion (0M2O) dividends here
What is Orion (0M2O)’s EPS estimate?
Orion (0M2O)’s EPS estimate is 0.41.
How many shares outstanding does Orion (0M2O) have?
Orion (0M2O) has 108,382,010 shares outstanding.
What happened to Orion (0M2O)’s price movement after its last earnings report?
Orion (0M2O) reported an EPS of €0.52 in its last earnings report, beating expectations of €0.492. Following the earnings report the stock price went up 5.209%.
Which hedge fund is a major shareholder of Orion (0M2O)?
Currently, no hedge funds are holding shares in GB:0M2O
---
Company Description
Orion (0M2O)
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company primarily focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries and North America.
---
0M2O Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering 0M2O
1 Year
1 Year Success Rate
1/2 ratings generated profit
1 Year Average Return
-10.60%
upgraded a buy rating 7 months ago
Copying Brian Balchin's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -10.60% per trade.
---